SPY759.91+0.01%QQQ689.80−0.08%BTC/USD74,411.75+0.97%DIA524.56+0.02%GLD365.12−0.01%TLT80.95+0.04%

TG Therapeutics Inc

TGTXNASDAQ

Trade with Public

$65.76

1.502.33%

Last update: Nov 11, 4:26 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Mon Nov 9th, before the market open

Conference Call: The most recent conference call started at 8:30 AM, 2 days ago

Click to view the webcast

TG Therapeutics (TGTX) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for TG Therapeutics (TGTX) stock.

Analyst Consensus — 8 Analysts

6Buy

1Hold

1Sell

# Analysts8

Latest Upgrades and Downgrades for TG Therapeutics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Evercore ISI Group	Michael DiFiore	PT Cut	Outperform	$73→$71
—	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$78
—	JP Morgan	Brian Cheng	PT Raise	Overweight	$65→$72
—	B. Riley Securities	William Woods	PT Raise	Buy	$55→$86
—	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$70→$77
—	B of A Securities	Alec Stranahan	PT Raise	Underperform	$17→$20
—	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$70
—	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$70
—	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$60→$70
—	JP Morgan	Brian Cheng	PT Cut	Overweight	$49→$46
—	Goldman Sachs	Corinne Johnson	PT Raise	Neutral	$37→$39
—	JP Morgan	Eric Joseph	PT Raise	Overweight	$46→$49
—	HC Wainwright & Co.	Emily Bodnar	Assumes	Buy	$60
—	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$53→$55
—	HC Wainwright & Co.	Edward White	Maintained	Buy	$55
—	HC Wainwright & Co.	Edward White	Maintained	Buy	$55
—	JP Morgan	Eric Joseph	PT Raise	Overweight	$30→$43
—	HC Wainwright & Co.	Edward White	PT Raise	Buy	$49→$55
—	Goldman Sachs	Corinne Jenkins	PT Raise	Neutral	$20→$22
—	TD Cowen	Tara Bancroft	Initiate	Buy	$50

TG Therapeutics Inc

TG Therapeutics (TGTX) Stock Price Target 2026

Latest Upgrades and Downgrades for TG Therapeutics Stock

TG Therapeutics (TGTX) Stock Price Target 2026

Latest Upgrades and Downgrades for TG Therapeutics Stock

Analyst Ratings News

PRO
Evercore ISI Group Maintains Outperform on TG Therapeutics, Lowers Price Target to $71

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Evercore ISI Group Maintains Outperform on TG Therapeutics, Lowers Price Target to $71

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

TG Therapeutics Inc

TG Therapeutics (TGTX) Stock Price Target 2026

Latest Upgrades and Downgrades for TG Therapeutics Stock

TG Therapeutics (TGTX) Stock Price Target 2026

Latest Upgrades and Downgrades for TG Therapeutics Stock

Analyst Ratings News

PROEvercore ISI Group Maintains Outperform on TG Therapeutics, Lowers Price Target to $71

PROHC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PROJP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PROB. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PROHC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PROB of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

People Also Watch

People Also Watch

Analyst Ratings News

PROEvercore ISI Group Maintains Outperform on TG Therapeutics, Lowers Price Target to $71

PROHC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PROJP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PROB. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PROHC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PROB of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

PRO
Evercore ISI Group Maintains Outperform on TG Therapeutics, Lowers Price Target to $71

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

PRO
Evercore ISI Group Maintains Outperform on TG Therapeutics, Lowers Price Target to $71

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20